Fig. 3.

Effect of different inductive agents on tolerance-associated transcripts expressed in peripheral blood of kidney transplant recipients during a 1-year follow-up period. Relative quantity (RQ) of FOXP3 (a) or TCAIM (b) measured by qRT-PCR in peripheral blood from patients treated with rATG (squares on dashed line), basiliximab (triangles on dotted line), or without induction (circles on solid line). Data are presented as estimated marginal means ± SEM